The robust weight loss combined with a well-tolerated safety profile reinforces our confidence in the clinical development programme as we advance to phase III trials. CT-388 is an important asset for unlocking the promise of our obesity pipeline, according to Roche, who added that the treatment is considered as a combination asset for petrelintide, an amylin analogue
Medications containing GLP-1 also known as GLP-1 receptor agonists are a class of drugs used to treat type 2 diabetes and other chronic conditions like obesity
Additionally, certain peptides function as growth factors or growth factor modulators, promoting tissue repair and regeneration
This article explores the connection between GLP-1 agonists and reflux symptoms, offering practical guidance aligned with UK clinical standards
In phase 3 trials, semaglutide and tirzepatide achieved between 14.9% and 20.9% reduction in body weight after one year, as well as improvement on cardiovascular risk factors (Jastreboff et al., 2022
The moment you add bacteriostatic water to your lyophilized retatrutide, the storage equation shifts dramatically
